Literature DB >> 22542099

Pathogenesis of rhinovirus infection.

Joshua L Kennedy1, Ronald B Turner, Thomas Braciale, Peter W Heymann, Larry Borish.   

Abstract

Since its discovery in 1956, rhinovirus (RV) has been recognized as the most important virus producing the common cold syndrome. Despite its ubiquity, little is known concerning the pathogenesis of RV infections, and some of the research in this area has led to contradictions regarding the molecular and cellular mechanisms of RV-induced illness. In this article, we discuss the pathogenesis of this virus as it relates to RV-induced illness in the upper and lower airway, an issue of considerable interest in view of the minimal cytopathology associated with RV infection. We endeavor to explain why many infected individuals exhibit minimal symptoms or remain asymptomatic, while others, especially those with asthma, may have severe, even life-threatening, complications (sequelae). Finally, we discuss the immune responses to RV in the normal and asthmatic host focusing on RV infection and epithelial barrier integrity and maintenance as well as the impact of the innate and adaptive immune responses to RV on epithelial function.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22542099      PMCID: PMC3378761          DOI: 10.1016/j.coviro.2012.03.008

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  65 in total

1.  Rhinovirus infection-induced alteration of tight junction and adherens junction components in human nasal epithelial cells.

Authors:  Nam-Kyung Yeo; Yong Ju Jang
Journal:  Laryngoscope       Date:  2010-02       Impact factor: 3.325

2.  Evidence for the direct involvement of the rhinovirus canyon in receptor binding.

Authors:  R J Colonno; J H Condra; S Mizutani; P L Callahan; M E Davies; M A Murcko
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

3.  Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection.

Authors:  J E Gern; R Vrtis; K A Grindle; C Swenson; W W Busse
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

4.  Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study.

Authors:  K G Nicholson; J Kent; V Hammersley; E Cancio
Journal:  BMJ       Date:  1996-11-02

5.  Effects of rhinovirus infection on the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells.

Authors:  Satoshi Ishizuka; Mutsuo Yamaya; Tomoko Suzuki; Hidenori Takahashi; Shiroh Ida; Takahiko Sasaki; Daisuke Inoue; Kiyohisa Sekizawa; Hidekazu Nishimura; Hidetada Sasaki
Journal:  J Infect Dis       Date:  2003-12-03       Impact factor: 5.226

6.  Experimental rhinovirus infection increases human tissue kallikrein activation in allergic subjects.

Authors:  Sandra C Christiansen; Jane Eddleston; Sara H Bengtson; Gavin R Jenkins; Robert B Sarnoff; Ronald B Turner; Jack M Gwaltney; Bruce L Zuraw
Journal:  Int Arch Allergy Immunol       Date:  2008-07-11       Impact factor: 2.749

7.  Exacerbations of asthma in adults during experimental rhinovirus infection.

Authors:  S A Halperin; P A Eggleston; P Beasley; P Suratt; J O Hendley; D H Gröschel; J M Gwaltney
Journal:  Am Rev Respir Dis       Date:  1985-11

8.  The September epidemic of asthma exacerbations in children: a search for etiology.

Authors:  Neil W Johnston; Sebastian L Johnston; Joanne M Duncan; Justina M Greene; Tatiana Kebadze; Paul K Keith; Madan Roy; Susan Waserman; Malcolm R Sears
Journal:  J Allergy Clin Immunol       Date:  2005-01       Impact factor: 10.793

9.  Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia.

Authors:  Leena Kainulainen; Tytti Vuorinen; Kaisu Rantakokko-Jalava; Riikka Osterback; Olli Ruuskanen
Journal:  J Allergy Clin Immunol       Date:  2010-06-11       Impact factor: 10.793

10.  The interleukin 6 -174 C/C genotype predicts greater rhinovirus illness.

Authors:  William J Doyle; Margaretha L Casselbrant; Ha-Sheng Li-Korotky; Allison P Cullen Doyle; Chia-Yee Lo; Ronald Turner; Sheldon Cohen
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

View more
  53 in total

1.  Productive Infection of Human Embryonic Stem Cell-Derived NKX2.1+ Respiratory Progenitors with Human Rhinovirus.

Authors:  Robert A Jenny; Claire Hirst; Sue Mei Lim; Adam L Goulburn; Suzanne J Micallef; Tanya Labonne; Anthony Kicic; Kak-Ming Ling; Stephen M Stick; Elizabeth S Ng; Alan Trounson; Antonietta Giudice; Andrew G Elefanty; Edouard G Stanley
Journal:  Stem Cells Transl Med       Date:  2015-04-14       Impact factor: 6.940

Review 2.  Human rhinoviruses.

Authors:  Samantha E Jacobs; Daryl M Lamson; Kirsten St George; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

Review 3.  Rhinoviruses and Their Receptors.

Authors:  Sarmila Basnet; Ann C Palmenberg; James E Gern
Journal:  Chest       Date:  2019-01-17       Impact factor: 9.410

4.  Arpin is critical for phagocytosis in macrophages and is targeted by human rhinovirus.

Authors:  Jamil Jubrail; Kshanti Africano-Gomez; Floriane Herit; Anna Mularski; Pierre Bourdoncle; Lisa Oberg; Elisabeth Israelsson; Pierre-Regis Burgel; Gaell Mayer; Danen M Cunoosamy; Nisha Kurian; Florence Niedergang
Journal:  EMBO Rep       Date:  2019-11-13       Impact factor: 8.807

5.  The Rhinovirus subviral a-particle exposes 3'-terminal sequences of its genomic RNA.

Authors:  Shushan Harutyunyan; Heinrich Kowalski; Dieter Blaas
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

6.  COVID-19 in Patients with Cancer.

Authors:  Ali Nowroozi; Sepideh Razi; Kamal Kant Sahu; Fabio Grizzi; Jann Arends; Mahsa Keshavarz-Fathi; Nima Rezaei
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Ethanolic Echinacea purpurea Extracts Contain a Mixture of Cytokine-Suppressive and Cytokine-Inducing Compounds, Including Some That Originate from Endophytic Bacteria.

Authors:  Daniel A Todd; Travis V Gulledge; Emily R Britton; Martina Oberhofer; Martha Leyte-Lugo; Ashley N Moody; Tatsiana Shymanovich; Laura F Grubbs; Monika Juzumaite; Tyler N Graf; Nicholas H Oberlies; Stanley H Faeth; Scott M Laster; Nadja B Cech
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

Review 8.  Experimental Antiviral Therapeutic Studies for Human Rhinovirus Infections.

Authors:  James A Coultas; John Cafferkey; Patrick Mallia; Sebastian L Johnston
Journal:  J Exp Pharmacol       Date:  2021-07-09

Review 9.  What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia?

Authors:  Andrew T Pavia
Journal:  Infect Dis Clin North Am       Date:  2012-12-12       Impact factor: 5.982

10.  Severity of rhinovirus infection in hospitalized adults is unrelated to genotype.

Authors:  Denise J McCulloch; Marti H Sears; Jesse T Jacob; G Marshall Lyon; Eileen M Burd; Angela M Caliendo; Charles E Hill; W Allan Nix; M Steven Oberste; Colleen S Kraft
Journal:  Am J Clin Pathol       Date:  2014-08       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.